New Enterprise Associates

New Enterprise Associates, Inc. is a private equity and venture capital firm established in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investments across various stages of company development, including seed, start-up, early stage, and later stage, with a focus on sectors such as information technology, healthcare, and energy technology. NEA's investment strategy encompasses a wide range of industries, including consumer internet, software, biotechnology, medical devices, and alternative energy. With over $19 billion in cumulative committed capital, the firm has a notable track record, having participated in more than 210 portfolio company IPOs and over 360 acquisitions. NEA aims to invest between $0.05 million and $20 million, targeting both domestic and international markets, particularly in Asia and the Americas.

Michael James Barrett

Partner Emeritus

Kate Barrett

Marketing Partner

Peter J. Barris

Chairman

Ronald D. Bernal

Venture Partner

Ron Bernal

Venture Partner

Tak Cheung

Partner

Philip Chopin

Managing Director

Louis Citron

Chief Administrative Officer and Chief Legal Officer

Robert Croce

Venture Advisor

Bala Deshpande

Sr. Managing Director, India

Lexi Eisenberg

Associate

Anthony A. Florence

Managing General Partner, Technology

Tony Florence

General Partner

Carol Gallagher

Advisor

Tracy Howe

Investment Professional

Suzanne Hooper King

Partner

Liza Landsman

General Partner

Michael Li

Investor

Tiffany Luck

Partner

Joshua Makower

General Partner

Edward T. Mathers

Partner

John Nehra

Retired Special Partner

Michael D. O'Dell

Venture Partner

Santhosh Palani

Principal

Greg Papadopoulos

Venture Partner

Arno Allan Penzias

Venture Advisor

Eugene A. Trainor

COO

James G. Treybig

Venture Advisor

Paul Walker

General Partner

Harry Weller

Former General Partner

Past deals in Series C

Mojo Vision

Series C in 2023
Mojo Vision is a developer of augmented reality products and platforms intended to invent the future of computing. The company has developed a smart contact lens with a built-in display that gives timely information without interrupting the focus and delivers immediate, powerful, and relevant information without the intrusions of today's mobile devices, enabling users to connect with others at a glance, anytime, anywhere handsfree. Mojo Vision was founded in 2015 and headquartered in Saratoga, California.

Moximed

Series C in 2022
Moximed, Inc. is focused on developing joint-preserving solutions for patients suffering from knee osteoarthritis. The company's primary product, the Atlas System, functions as an implantable joint unloader, similar to a shock absorber, specifically targeting individuals experiencing pain in the medial compartment of the knee. This innovative approach aims to alleviate joint pain, reduce dynamic load, and potentially delay the necessity for more invasive surgical interventions. Moximed seeks to enhance the standard of care for osteoarthritis patients, helping them maintain an active lifestyle while serving both patients and medical professionals globally. Established in 2006 and headquartered in Hayward, California, Moximed was previously known as ExploraMed NC4, Inc.

Super

Series C in 2022
Super is the first Indonesian consumer technology company backed by Y Combinator, which oversees the main feature, Superagen. Superagen is agent-led commerce group buying that enables community leaders to become retailers within their communities. We use technology to: 1) Empower community leaders to become self-made entrepreneurs by enabling them to sell various products to their communities 2) Build a logistics network with the lowest cost 3) Facilitate communication for social-buying behavior so our agents can sell various products through social networks like WhatsApp

Genies

Series C in 2022
Genies, Inc. is a mobile application company based in Venice, California, that specializes in the creation of personalized digital avatars. Founded in 2017, Genies allows users to design their own avatars with a wide range of clothing and facial options, enabling them to express their identity in social media and messaging platforms. The company also offers an Avatar Agency and SDK, facilitating the integration of avatars into various aspects of culture and commerce. In addition to avatar creation, Genies develops a social sharing application targeted at college students, allowing them to share experiences and engage with brands. This platform enables students to earn recognition through snaps (likes) from peers and redeem them for rewards, while brands can connect with this desirable demographic. Genies aims to enhance user engagement and provide brands with opportunities to sell exclusive digital goods through their interactive avatar experiences.

Built Robotics

Series C in 2022
Built Robotics Inc. develops automation technology solutions for the construction industry. It develops AI guidance systems to transform heavy equipment into autonomous robots, which combines various sensors, such as GPS, cameras, and Lidar with advanced software. The company’s guidance systems are deployed on earthmoving equipment, and used to build critical infrastructure, such as wind farms, oil and gas pipelines, mining, and new housing developments. Built Robotics Inc. was founded in 2016 and is headquartered in San Francisco, California.

Timescale

Series C in 2022
Timescale, Inc. owns and operates data analysis platform for scale, ease of use, and complex queries. Its product includes TimescaleDB, which is an open source time-series database that supports full SQL; and Community, which is a software developed for time-series database optimized for advanced analytics and built for production use cases. Timescale, Inc. was formerly known as IoBeam. The company was incorporated in 2011 and is based in New York, New York with additional offices in Stockholm, Sweden and Los Angeles, California.

Beyond Identity

Series C in 2022
Beyond Identity's mission is to empower the next generation of secure digital business by replacing passwords with fundamentally secure X.509-based certificates. This patent-pending approach creates an extended Chain of Trust that includes user and device identity and a real-time snapshot of the device’s security posture for adaptive risk-based authentication and authorization. Beyond Identity’s cloud-native solution enables customers to increase business velocity, implement new business models, reduce operating costs, and achieve complete passwordless identity management.

FTX

Series C in 2022
FTX Trading LTD operates a cryptocurrency derivatives exchange and trading platform for traders and investment professionals. Its platform offers futures trading, leveraged tokens, and an OTC portal. The company’s platform supports quarterly and perpetual futures on various cryptocurrencies and altcoins, such as bitcoin, ether, binance coin, and tether, as well as various altcoin, midcap, and other indices. The company was founded in 2017 and is based in San Francisco, California.

Virtru

Series C in 2022
Virtru Corp., founded in 2011 and headquartered in Washington, D.C., specializes in data security and privacy technologies. The company empowers organizations to effectively manage and protect their data throughout its entire lifecycle, from creation to sharing. Virtru is known for developing the Trusted Data Format (TDF), which serves as an open industry standard for persistent data protection. With a focus on flexibility and ease of use, Virtru's data protection platform enables over 20,000 organizations across various sectors to maintain control over their data while ensuring compliance with privacy regulations.

inCarey

Series C in 2021
InCarey is a leading domestic comprehensive service platform focusing on the management of patients with chronic diseases and vertical diseases. It is committed to providing one-stop Internet medical, pharmaceutical, and medical services for patients with long-term, heavy-service, and high-value chronic diseases. Innovative payment services.

Forethought

Series C in 2021
Forethought Technologies, Inc. is an AI company that specializes in developing advanced models for question-answering and information retrieval to enhance employee workflows. Founded in 2017 and based in Palo Alto, California, the company offers a platform known as Agatha, an AI-powered customer support agent designed to streamline customer interactions. Agatha effectively addresses customer inquiries, automates repetitive tasks, and provides real-time assistance to support agents, thereby improving operational efficiency. The company’s tools also enable businesses to enhance accuracy in finding solutions and managing workloads, ultimately reducing resolution times and increasing agent productivity. Forethought’s innovative approach aims to transform how enterprises access and utilize knowledge within their operations.

Anyscale

Series C in 2021
Anyscale, Inc. is a company that develops and operates platforms and tools for distributed programming, specifically aimed at simplifying the development of distributed AI applications. The company offers a platform built on an open-source framework called Ray, which allows software developers and machine learning engineers to scale their applications more efficiently. Founded in 2019 and headquartered in Berkeley, California, Anyscale focuses on enabling developers to create compute-intensive applications without needing to manage complex hardware decisions. Originally known as Indigostack, Inc., the company rebranded to Anyscale in November 2019, reflecting its commitment to providing accessible solutions for distributed application development.

Block Renovation

Series C in 2021
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

Stride Health

Series C in 2021
Stride Health, Inc. operates a health benefits platform that allows independent workers and part-time employees to select and enroll in affordable health coverage. It offers dental plans, drive plans, and doctor and prescription insurance plans. The company serves customers in the United States. Stride Health, Inc. was formerly known as Covered, Inc. and changed its name to Stride Health, Inc. in March 2013. The company was incorporated in 2013 and is based in San Francisco, California.

Clarifai

Series C in 2021
Clarifai, Inc. specializes in advanced image recognition technology, allowing users to detect near-duplicates and conduct visual searches. The company's systems can identify various categories, objects, and tags within images, enabling the discovery of similar images in large, uncategorized repositories through a combination of semantic and visual similarity. Additionally, Clarifai offers Labeler, a tool designed for labeling unstructured datasets, facilitating data search using artificial intelligence, training AI models, and auto-scaling models in production. Founded in 2013, Clarifai is headquartered in New York, with an additional office in Tallinn, Estonia.

Sisu

Series C in 2021
Sisu is the fastest and most comprehensive diagnostic platform for structured data. Based on years of research at Stanford University and proven at scale at Microsoft, Facebook and Google, Sisu’s diagnostic analytics platform combines machine learning and powerful statistical analysis to help anyone get answers to their toughest business questions. To learn more about Sisu, visit www.sisu.ai.

Pager

Series C in 2021
Pager, Inc. develops and operates an on-demand service platform that connects patients with healthcare in their home, office, and hotel. The company offers Pager, a location-based mobile application that connects users with care to treat their urgent care needs, including urinary tract infection, upper respiratory infection, strep throat, fever, bronchitis, influenza, cold, nausea, back pain, rashes, burns, allergy, asthma, and others. It also provides nurse chat, teleconsult, screening, vaccination, and prescription delivery services. The company was formerly known as techCare, Inc. and changed its name to Pager, Inc. in July, 2014. Pager, Inc. was incorporated in 2013 and is based in New York, New York.

Allay Therapeutics

Series C in 2021
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation. The company was founded in 2017 and is headquartered in Menlo Park, California, United States.

Tulip Interfaces

Series C in 2021
Tulip Interfaces, Inc. is a company that specializes in developing applications for the manufacturing sector. Founded in 2012 and based in Somerville, Massachusetts, Tulip offers a Manufacturing App Platform that integrates data from various sources, including sensors, to create real-time digital work instructions and visualizations. This platform connects existing shop floor equipment with operator inputs, enhancing operational efficiency. Tulip's technology leverages advancements in intelligent hardware, computer vision, user interfaces, and machine learning, bridging the gap between traditional manufacturing IT systems and the dynamic needs of the shop floor. The company serves a diverse range of industries, including consumer electronics, pharmaceuticals, apparel, and medical devices, with its solutions deployed across multiple global customers.

Aetion

Series C in 2021
Aetion, Inc. develops a science and analytics platform to assess real-world evidence (RWE) from a range of sources. The company offers Aetion Evidence Platform, a platform that generates RWE needed by healthcare decision makers to engage in value-based care. Its solution allows payers, providers, medical device makers, biopharma customers, and academic institutions to analyze data from various clinical and financial interactions in healthcare, including claims, electronic health records, registries, and clinical trials. The company’s platform is also used in database analytics and comparative effectiveness courses taken by epidemiologists, outcomes researchers, health economists, and biostatisticians. It serves customers worldwide. Aetion, Inc. has a strategic collaboration with McKesson. The company was founded in 2012 and is based in New York, New York.

Willow

Series C in 2021
Willow is a female technology company that develops an in-bra wearable breast pump. Its breast pumps are cordless and spill-proof. It also tracks milk output through a mobile application along with an online portal, enabling mothers to pump anywhere without hassle. The company was founded in 2014 and is headquartered in Mountain View, California.

Arcellx

Series C in 2021
Arcellx is a privately held development-stage company founded in 2015 and located in Montgomery County, Maryland. The Arcellx team is devoted to providing patients with superior immune cell therapies through scientific innovation, accelerated development, and responsible patient care. Although our initial clinical focus is cancer therapy, we are committed to extending our Antigen- Receptor Complex T cell (ARC-T) therapies across a broad spectrum of human disease.

Cleo

Series C in 2021
Cleo Labs, Inc. is a San Francisco-based company that offers pregnancy consultancy and parenthood guidance services, assisting families from fertility through to parenting children up to age five. The company provides a range of consultation services, including lactation support, birth preparation, child wellness, immediate post-birth assistance, career coaching, safety gear advice, sleep consulting, and emotional support for parents. Cleo delivers its services via a mobile application, making it accessible to both employers and families. Many organizations partner with Cleo to enhance their family support systems, aiming to improve employee retention, foster diverse and inclusive workplaces, and reduce health-related claims. Cleo operates in over 50 countries and collaborates with notable companies such as eBay, LinkedIn, and Uber. The company was founded in 2016 and underwent a name change from Instacare Group, Inc. in July 2018.

Monte Rosa Therapeutics

Series C in 2021
Monte Rosa Therapeutics is a biotechnology company based in Basel, Switzerland, that specializes in developing innovative cancer therapeutics through the modulation of protein degradation pathways. The company focuses on molecular glue degraders (MGDs), a class of small molecule drugs that utilize the body's natural mechanisms for protein degradation to selectively target and degrade proteins relevant to cancer treatment. Monte Rosa employs its QuEEN platform, which integrates artificial intelligence and proprietary experimental tools, to identify and develop target proteins for degradation. With a library of over 50,000 MGD molecules, its leading product candidate, MRT-2359, specifically targets the translation termination factor protein GSPT1, showing potential for treating MYC-driven tumors. The company is committed to advancing its pipeline of novel therapeutics to address unmet medical needs in oncology.

Nuvolo

Series C in 2021
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform built on the ServiceNow framework. Established in 2013 and headquartered in Paramus, New Jersey, with additional offices in London, Bulgaria, and India, Nuvolo specializes in life-cycle management solutions for assets in clinics, laboratories, facilities, and manufacturing sectors. The company provides a comprehensive suite of services that includes implementation, support, tracking, reporting, and analytics, aimed at enhancing the user experience for mobile and remote workforces. Known for its commitment to innovation and customer service, Nuvolo has formed strategic partnerships with major firms such as Atos, KPMG, and Unisys to further its mission of becoming a leader in cloud-based enterprise asset management.

Burrow

Series C in 2021
Burrow, Inc. is a furniture design and manufacturing company based in New York, founded in 2016. It specializes in creating luxury furniture for homes, offering a diverse range of products including sofas, sectionals, sleepers, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories like pillows and throws. The furniture is handcrafted from sustainably-sourced hardwood and features non-toxic, scratch- and stain-resistant fabrics. Burrow sells its products through physical showrooms located in several states, including Washington, Massachusetts, Texas, and California, as well as online. The company also operates a manufacturing facility in Mexico City, Mexico.
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. They were the first to sequence and analyze whole human cancer exomes and subsequently identified many alterations responsible for the development of cancer. They have described the principles underlying the genetic basis of human cancer and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Through PGDx, our founders bring their proprietary methods and expertise to research teams worldwide. The services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Their expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. They specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Personal Genome Diagnostics was founded in 2010 and is based in Baltimore, Maryland, United States.

Sitetracker

Series C in 2021
SiteTraker is a cloud-based project management platform that powers the successful deployment of critical infrastructure. The platform enables growth-focused innovators to optimize the entire asset lifecycle. The company was founded in 2013 and is headquartered in Palo Alto, California.

KONUX

Series C in 2021
KONUX GmbH, founded in 2014 and based in Munich, Germany, develops Industrial Internet of Things (IIoT) solutions that integrate smart sensor systems with artificial intelligence analytics. The company specializes in enhancing railway operations, offering a range of services including switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and predictive maintenance. KONUX's solutions enable real-time monitoring of infrastructure conditions and improve operational efficiency, capacity, and reliability in railway and industrial applications. The company has attracted significant investment, raising over $50 million and expanding its presence across Europe and Asia. Recognized by the World Economic Forum as one of the world's most innovative start-ups, KONUX is committed to transforming railway mobility for a sustainable future.

Bestow

Series C in 2020
Bestow Inc. is a digital insurance company based in Dallas, Texas, specializing in life insurance services. Founded in 2016, Bestow leverages data-driven technology and algorithmic underwriting to assess risks and streamline the insurance process. The company's fully digital platform allows individuals and families to access and purchase affordable life insurance policies quickly, often within minutes, using their mobile devices. In addition to serving consumers directly, Bestow offers APIs that enable partner companies to seamlessly integrate life insurance coverage into their own offerings, thereby expanding market access and enhancing distribution channels.

Alfred

Series C in 2020
Alfred is an end-to-end resident experience and building management platform that is changing the way people live and transforming the real estate industry. Operating at the intersection of real estate and technology, Alfred builds intuitive, personal support into one of the most important spaces of our lives: our homes. Named one of the Top 50 Most Innovative Companies in the World by Fast Company in the urban development space, Alfred has been recognized in The New York Times, The Financial Times, and Wall Street Journal, as a pioneer in the on-demand economy, following their decision to hire Alfred Home Managers as W-2 employees (complete with benefits, training, and the ability to move up in the organization) and its support of local ecosystems and neighborhood businesses. Hello Alfred was founded in 2014 by Marcela Sapone and Jessica Beck, and is headquartered in New York, New York, United States.

Willow

Series C in 2020
Willow is a female technology company that develops an in-bra wearable breast pump. Its breast pumps are cordless and spill-proof. It also tracks milk output through a mobile application along with an online portal, enabling mothers to pump anywhere without hassle. The company was founded in 2014 and is headquartered in Mountain View, California.

Everactive

Series C in 2020
Everactive's custom ultra-low-power chips enable completely battery-less wireless sensors that form the foundation of end-to-end IoT data services. The company technology allows for low cost, long-lived, and intelligent instrumentation of industrial operations. Its end-to-end solutions are built upon innovative advances in ultra-low-power circuit design and wireless communication that enable the company to power its Eversensors exclusively from harvested energy. The company also creates networking and cloud software to provide a service focused on providing customers with valuable insights from generated and self-sustaining data streams. The company was founded on 2012 and is based in Santa Clara, California.

Amplyx Pharmaceuticals

Series C in 2020
Amplyx Pharmaceuticals is a pre-clinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The company develops innovative therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx Pharmaceuticals was founded in 2006 and is headquartered in San Diego, California.

Willow

Series C in 2019
Willow is a female technology company that develops an in-bra wearable breast pump. Its breast pumps are cordless and spill-proof. It also tracks milk output through a mobile application along with an online portal, enabling mothers to pump anywhere without hassle. The company was founded in 2014 and is headquartered in Mountain View, California.

ChromaCode

Series C in 2019
ChromaCode, Inc. is a molecular diagnostics company based in Carlsbad, California, specializing in testing solutions for infectious diseases, cancer, and non-invasive prenatal testing (NIPT). Founded in 2012, the company leverages patented mathematical methods and algorithmic enhancements derived from Caltech intellectual property to improve signal processing in life science instrumentation. This technology enables ChromaCode to significantly enhance the multiplexing capabilities of quantitative polymerase chain reaction (qPCR) instruments, allowing for more efficient and cost-effective biochemical assays. Among its offerings is the HDPCR Tick-Borne Pathogen Panel, which detects multiple common tick-borne pathogens in a single test. ChromaCode’s expertise is bolstered by a team with backgrounds in leading organizations such as Illumina, Google[x], and Luminex.
Black Diamond Therapeutics is a precision oncology medicine company focused on discovering and developing small molecule, tumor-agnostic therapies. The company's lead product candidate, BDTX-189, is designed to inhibit specific mutations in ErbB kinases, including the epidermal growth factor receptor. Additionally, Black Diamond is advancing a pipeline of allosteric-EGFR mutation inhibitors and other early-stage programs targeting allosteric mutations in kinases associated with cancer and rare genetic diseases. The company employs a technology platform known as Mutation-Allostery-Pharmacology, which aims to address undrugged mutations in patients with genetically defined cancers. Founded in 2014 and based in Cambridge, Massachusetts, Black Diamond Therapeutics was previously known as ASET Therapeutics until its rebranding in 2018.

Sentry

Series C in 2019
Sentry is an open-source platform for workflow productivity, aggregating data from errors and crashes across the stack in real time. The company's tool shows every crash in stack as it happens, with the details needed to prioritize and identify it, as well as offers insight into deployments and information to reproduce and fix crashes, enabling users to see which errors are doing the most harm to their business and helps them to understand how issues affect their bottom line.

PlayVS

Series C in 2019
PlayVS is an operator of an eSports platform used to organize competitions in eSports on behalf of high school. Its platform offers to organize online tournaments and wagers for cash and prizes and helps to play and stay up-to-date on high school e-sports programs that enable teen gamers to form teams at their high schools to compete with players from other schools and the battle for titles at state championships.

Echodyne

Series C in 2019
Echodyne develops and manufactures meta-materials-based radar technologies. The company combines the patented technology of metamaterials with powerful software to create a radar sensor with unprecedented performance at commercial price points. Echodyne's patented technology and powerful software create a high-performance radar platform that produces security and machine autonomy solutions for government, defense, and industry. Echodyne was founded in 2014 and is headquartered in Kirkland, Washington.

Heap

Series C in 2019
Heap Inc. develops an analytics infrastructure designed for online businesses, enabling them to capture and analyze web, mobile, and cloud interactions, such as clicks and transactions. Founded in 2012 and headquartered in San Francisco, California, with additional offices in New York and Utah, Heap's solution automates the analytics process, allowing companies to focus on deriving insights and making informed business decisions. The platform provides a comprehensive view of customer data, helping businesses optimize product offerings and enhance user experiences. Heap serves over 6,000 clients across various industries, including e-commerce, financial services, and software as a service (SaaS), with notable customers such as Twilio, LendingClub, and Optimizely.

Expel

Series C in 2019
Expel, Inc. is a managed security software company that specializes in providing SOC-as-a-service, which includes security monitoring and response for cloud, hybrid, and on-premises environments. Founded in 2016 and based in Herndon, Virginia, Expel leverages existing security signals from its customers to enhance the value of their current security investments. By connecting to customer technology remotely via APIs rather than agents, Expel can initiate monitoring within hours, allowing internal teams to concentrate on their unique security priorities. The company aims to streamline and improve the security operations of organizations, enabling them to respond effectively to emerging threats.

Tamara Mellon

Series C in 2019
Tamara Mellon, LLC offers apparel and accessories for women. It offers shoes, including sandals, boots, pumps, flats, and legging boots; bags and accessories; and ready to wear solutions, such as dresses, jumpsuits and rompers, tops and knitwear, pants and skirts, and jackets and outerwear. The company sells its products through retail and online stores in the United States and internationally. Tamara Mellon, LLC was incorporated in 2011 and is headquartered in New York, New York.

Divvy

Series C in 2019
Divvy software gives you complete control and real-time visibility into company spending while eliminating the hassle of expense reports. Divvy is a secure financial platform for businesses to manage payments and subscriptions, build strategic budgets, and eliminate expense reports. By integrating real-time tracking for every business transaction, Divvy provides organizations with instant insight into their spend. With Divvy, you can make informed cash flow decisions, curb losses before they happen, and never have to save a receipt again. The company was founded in 2016 and is based in Lehi, Utah.

Expanse

Series C in 2019
Expanse, Inc., through its platform offers data marshalling services. The company was formerly known as Qadium, Inc. and changed its name to Expanse, Inc. in October 2018. Expanse, Inc. was incorporated in 2012 and is based in San Francisco, California.

Igneous

Series C in 2019
Igneous Systems, Inc., founded in October 2013 and headquartered in Seattle, Washington, specializes in enterprise data center infrastructures and offers a comprehensive Unstructured Data Management (UDM) as-a-Service solution. This innovative service provides data-centric organizations with enhanced visibility, protection, and mobility for their unstructured data at scale. By integrating various UDM functions into a single, cloud-native platform, Igneous enables businesses to maximize the value of their data while minimizing risks and optimizing the use of IT resources.

Trevi Therapeutics

Series C in 2019
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an investigational therapy. The company's lead product, Haduvio, is an oral extended-release formulation of nalbuphine currently undergoing Phase IIb/III clinical trials. Trevi Therapeutics is focused on addressing serious neurologically mediated conditions, including chronic pruritus, chronic cough associated with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in Parkinson's disease patients. The ongoing PRISM trial evaluates Haduvio's effectiveness in treating severe pruritus related to prurigo nodularis, highlighting its potential in managing conditions linked by a common pathophysiology involving opioid receptors in the nervous system. Founded in 2011, Trevi Therapeutics aims to provide innovative therapeutic solutions for patients with significant unmet medical needs.

The Wing

Series C in 2018
The Wing is a network of work and community spaces designed for women with locations in New York, California, and Washington, D.C. The Wing’s mission is the professional, civic, social, and economic advancement of women through the community.

Annexon Biosciences

Series C in 2018
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune and neurodegenerative diseases. It focuses on the treatment of body, brain, and eye disorders. The company’s C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, which has completed Phase 1b clinical trials to treat patients with guillain- barré syndrome; and ANX007, which has completed Phase 1b clinical trials to treat patients with glaucoma. The company’s candidates also comprise ANX005 that has completed preclinical trials to treat patients with warm autoimmune hemolytic anemia, Huntington's disease, and amyotrophic lateral sclerosis; ANX007, which has completed preclinical trials for the treatment of geographic atrophy; and ANX009 that has completed preclinical trials for the treatment of systemic autoimmune diseases. The company was founded in 2011 and is headquartered in South San Francisco, California.

Plaid

Series C in 2018
Plaid Inc. is a technology platform that enables users to connect their bank accounts to various applications, aiming to democratize financial services through innovative solutions. Founded in 2012 and based in San Francisco, Plaid provides a suite of APIs that allow developers to create financial products that connect consumers with traditional financial institutions. Its offerings include tools for accessing transaction history, authenticating bank accounts, verifying identities, and checking real-time account balances and income. These products are utilized across various sectors, including personal finance, consumer payments, lending, banking, and brokerage. Plaid serves a wide range of clients, from startups to Fortune 50 companies, facilitating the development of modern financial services and applications.

Neuehealth

Series C in 2018
NeueHealth is a health care service platform that focuses on improving patient experiences and outcomes through a combination of technology and local healthcare resources. It operates 61 affiliated primary care clinics that deliver both virtual and in-person clinical care to nearly 75,000 unique patients. NeueHealth is part of Bright Health Group, which also offers Medicare and commercial health plan products to approximately 623,000 consumers across 14 states. The company aims to reduce healthcare costs while enhancing access and quality of care by aligning the interests of consumers, providers, and payers. Founded in 2015 and based in Minneapolis, Minnesota, NeueHealth leverages intelligent technology to connect users with healthcare services and providers effectively.

Infoworks.io

Series C in 2018
Infoworks' Enterprise Data Operations and Orchestration (EDO2) system was built to automate and accelerate development, deployment and orchestration of analytics projects at scale, in cloud, hybrid, multi-cloud, and premise-based environments. Through deep automation and a code-free environment, Infoworks empowers organizations to rapidly consolidate and organize enterprise data, create analytics pipelines and deploy projects to production within days – dramatically increasing business agility and accelerating time-to-value. Infoworks counts some of the world’s largest financial, retail, technology, healthcare, oil & gas, and manufacturing companies as its customers.

OmniSci

Series C in 2018
OmniSci, Inc. specializes in accelerated analytics solutions powered by graphics processing units (GPUs). Its analytics platform enables users to interactively query and visualize data, facilitating data science workflows across vast datasets. This technology is utilized by various sectors, including automotive, insurance, investment management, logistics, media, oil and gas, pharmaceuticals, telecommunications, utilities, and public services. The platform stands out by allowing organizations to derive insights from data far beyond the capabilities of conventional analytics tools. OmniSci's origins trace back to research at Harvard and the MIT Computer Science and Artificial Intelligence Laboratory. Established in 2013 and headquartered in San Francisco, the company has formed strategic partnerships with several prominent investors and firms, including Google Ventures, In-Q-Tel, and NVIDIA. OmniSci aims to support both business and government entities in leveraging data for informed decision-making.

Galera Therapeutics

Series C in 2018
Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics that aim to enhance the effectiveness of radiotherapy in cancer treatment. The company’s lead product candidate, avasopasem manganese (GC4419), is a small molecule mimetic of superoxide dismutase designed to address radiation-induced severe oral mucositis in patients with head and neck cancer. It is currently undergoing Phase III clinical trials for this indication and Phase IIa trials for treating radiotherapy-induced esophagitis in lung cancer patients. Additionally, Galera is developing a second candidate, GC4711, which is in Phase I/II trials for pancreatic and lung cancers. Founded in 2012 and headquartered in Malvern, Pennsylvania, Galera Therapeutics is dedicated to transforming cancer treatment through advancements in oxygen metabolic pathways.

Enigma

Series C in 2018
Enigma Technologies, Inc. is a New York-based operational data management and intelligence company that offers a comprehensive searchable database of public records and documents. Its core offerings include Enigma Data Infrastructure, which encompasses tools for data operations and search capabilities, and Enigma Solutions, tailored products and services for industries such as financial services, healthcare, and insurance. The company provides analysis-ready public data and operates Enigma Labs to develop open data tools for public use. Additionally, Enigma offers an application programming interface (API) to facilitate application development and various data services, including entity resolution and custom data acquisition. By delivering timely and accurate insights into small businesses' identities and risk profiles, Enigma supports organizations like American Express and PayPal in making informed operational decisions. Founded in 2011, Enigma continues to bridge the gap between data and workflows, enhancing decision-making processes across sectors.

StreamSets

Series C in 2018
StreamSets, Inc. provides a cloud-based DataOps platform designed for modern data integration, enabling enterprises to continuously manage big, streaming, and traditional data for data science and analytics applications. The company offers several key products, including StreamSets Control Hub for designing and monitoring data pipelines, StreamSets Data Collector for executing these pipelines without the need for hand coding, and StreamSets Transformer for building data transformations across various sources on Spark clusters. StreamSets' solutions support various applications, including data lake and warehouse integration, cloud data storage adoption, and real-time application development. Founded in 2014, StreamSets is headquartered in San Francisco, California, with additional offices in Sunnyvale, Austin, London, Barcelona, Bengaluru, and Sydney, serving clients both in the United States and internationally.

Trevi Therapeutics

Series C in 2018
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an investigational therapy. The company's lead product, Haduvio, is an oral extended-release formulation of nalbuphine currently undergoing Phase IIb/III clinical trials. Trevi Therapeutics is focused on addressing serious neurologically mediated conditions, including chronic pruritus, chronic cough associated with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in Parkinson's disease patients. The ongoing PRISM trial evaluates Haduvio's effectiveness in treating severe pruritus related to prurigo nodularis, highlighting its potential in managing conditions linked by a common pathophysiology involving opioid receptors in the nervous system. Founded in 2011, Trevi Therapeutics aims to provide innovative therapeutic solutions for patients with significant unmet medical needs.

MORE Health

Series C in 2018
MORE Health, Inc. is a healthcare technology company that offers a cloud-based platform designed to enhance physician collaboration. This platform connects patients' attending doctors with specialists to collaboratively develop accurate diagnoses and optimal treatment plans. Key features include a clinical database containing medical histories, hospital records, and lab results, as well as medical imaging tools and HIPAA-compliant video conferencing for discussions. The company also provides a patient portal for personal health records, an Overseas Co-Diagnosis service for international patients, and secure medical record services for traveling employees. Originally established as a concierge service for individuals, MORE Health now extends its offerings to U.S. companies as an employer-sponsored health benefit, facilitating access to top physicians for serious medical issues through Co-Diagnosis or Independent Second Opinion services. Founded in 2013 and based in Foster City, California, MORE Health collaborates with renowned medical institutions, including The George Washington Medical Faculty Associates, Boston Children's Hospital, and UCLA Health, with the aim of becoming a virtual global hospital for serious illnesses.

Brandless

Series C in 2018
Based in San Francisco, Brandless is a fresh approach to consumer commerce. Their mission is deeply rooted in quality, transparency, and community-driven values. Starting with everyday essentials, the things they use all the time, Brandless will make it possible for everyone to have access to better stuff for fewer dollars. Brandless is co-founded by Tina Sharkey and Ido Leffler and is slated to launch in the spring of 2017.

Tuya

Series C in 2018
Tuya is a global "AI+IoT" developer platform, and the world's leading voice AI interactive platform, connecting consumers, manufacturing brands, OEMs and retail chains, providing customers with a one-stop artificial intelligence Internet of Things solution, and covering hardware access, cloud services and App development, forming a closed loop of AI + manufacturing, providing technology and business model upgrade services for business with consumer IoT smart devices, in order to meet consumers' higher demands for hardware products. As of the end of October 2018, Tuya Smart has served 93,000 customers worldwide, connecting more than 100 million smart products in the market, creating a completely neutral "AI+IoT" model for empowering products, with total product listings of more than 30,000, selling to nearly 200 countries and regions. On the global IoT cloud platform with a distributed architecture, the daily processing device requests have reached nearly 50 billion times, daily voice AI interaction has exceeded 20 million times, and the accumulated data volume has reached 15 petabytes.

Framebridge

Series C in 2018
Framebridge, Inc. specializes in custom framing solutions for art and photographs, offering a streamlined online service that prioritizes customer experience. Founded in 2014 and based in Washington, D.C., the company allows users to select from a curated range of contemporary frame styles, upload images, or send physical items for personalized framing. The expert team at Framebridge handcrafts frames to meet each customer's specifications, ensuring high-quality results. Finished products are shipped directly to consumers, typically arriving within days and ready to hang. Pricing is transparent and based on the size of the framed item, starting at $39 and including free shipping. Framebridge operates manufacturing facilities in Richmond, Kentucky, and Lanham, Maryland, and has attracted investments from notable firms and individuals in the retail and technology sectors.

NGINX

Series C in 2018
NGINX now part of F5 is the company behind the popular open-source project. It offers a suite of technologies for developing and delivering modern applications. Together with F5, our combined solution bridges the gap between NetOps and DevOps, with multi-cloud application services that span from code to customer. NGINX was incorporated in 2011 and headquartered in San Francisco, California.

Metacrine

Series C in 2018
Metacrine is a clinical-stage biopharmaceutical company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases. The most advanced program is focused on the farnesoid X receptor (FXR) an important drug target in multiple liver and GI diseases. Beyond the FXR program, a pipeline of novel drug candidates against other drug targets is being explored by taking advantage of internal drug discovery and development capabilities.

XSKY Data Technology

Series C in 2018
XSky (Beijing) Data Technology Co., Ltd. is a Chinese company specializing in software-defined infrastructure products and services. It offers a range of storage solutions, including XCBS for cloud storage, XEBS for block storage, XEUS for unified storage, XEOS for object storage, and XEDP as a unified data platform. The company also provides software-defined storage solutions with its XSCALER series. XSky serves various sectors, including finance, healthcare, education, telecommunications, and energy, catering to enterprises, government agencies, and media networks. In addition to its product offerings, XSky is a significant contributor to the open-source storage system Ceph and is recognized as a leading partner of Red Hat in China. The company collaborates with major IT firms like Intel and Dell to enhance its technology and solutions, focusing on scalable and future-ready storage options.

Intact Vascular

Series C in 2018
Intact Vascular, Inc., a medical device company, develops medical devices for minimally invasive peripheral vascular procedures. The company offers Tack Endovascular System, a device that offers optimization of peripheral balloon angioplasty results during the treatment of peripheral arterial disease (PAD) and critical limb ischemia (CLI). Intact Vascular, Inc. was formerly known as Tackit Vascular LLC. The company was founded in 2011 and is based in Wayne, Pennsylvania.

Goop

Series C in 2018
Goop Inc. is a lifestyle brand that operates an online platform offering wellness advice, curated shopping experiences, and digital content. Founded in 2008 by Gwyneth Paltrow, the brand began as a newsletter sharing travel recommendations and health-related recipes. It has since evolved into a comprehensive lifestyle website featuring a range of products, including apparel, beauty items, and wellness products. Goop provides expert advice on health, personal care, and home decoration, along with cooking tutorials and gift guides. The platform emphasizes a curated approach to content and commerce, allowing readers to benefit from Paltrow’s personal experiences and the expertise of various mentors. Goop also features an exclusive skincare line, reflecting its commitment to quality and clean ingredients. With its origins in a simple newsletter, Goop has grown into a trusted resource for lifestyle insights and shopping recommendations.

DataVisor

Series C in 2018
DataVisor is the fraud and financial crime detection service utilizing unsupervised machine learning to identify attack campaigns before they conduct any damage. DataVisor protects some of the largest organizations in the world from attacks such as account takeovers, fake account creation, money laundering, fake social posts, fraudulent transactions and more.

Fire1

Series C in 2018
Fire1, based in Dublin, Ireland, is dedicated to developing innovative therapeutic devices aimed at enhancing the lives of heart failure patients. The company has created a remote monitoring system that allows healthcare providers to access real-time patient data and insights. This technology facilitates the early detection of complications associated with heart failure, enabling proactive interventions that can lead to improved patient outcomes. Through its focus on remote monitoring, Fire1 seeks to address critical challenges in heart failure management and contribute to better healthcare solutions.

Metavention

Series C in 2018
Metavention, Inc., established in 2012 and headquartered in Dover, Delaware, specializes in the development of trans-catheter devices aimed at modulating sympathetic nervous system activity. These innovative devices address the issues of over-active sympathetic nerves that contribute to elevated glucose levels and abnormal liver function. By employing standard interventional vascular techniques, Metavention provides healthcare professionals with a novel tool for diagnosing and treating patients with Type 2 diabetes. The company focuses on enhancing treatment options for this condition, ultimately improving patient outcomes.

ThreatQuotient

Series C in 2017
ThreatQuotient is a threat intelligence platform (TIP) that centrally manages and correlates unlimited external sources with all internal security and analytics solutions for contextual, operationalized intelligence in a single pane of glass. ThreatQ is also the first TIP to provide Indicator Nurturing, which goes beyond enrichment to help customers tailor indicators of compromise (IOCs) more specifically to their infrastructure. Headquartered in Northern Virginia, ThreatQuotient was founded in 2013 by two former security operations analysts to provide organizations the ability to correlate with confidence.

Eargo

Series C in 2017
Eargo, Inc. is a consumer-focused medical device company based in San Jose, California, that specializes in developing and selling innovative hearing aids for individuals experiencing hearing loss. Founded in 2010, Eargo offers a range of rechargeable hearing aids that can be controlled via smartphone, addressing common barriers to hearing aid adoption such as cost, accessibility, and social stigma. The company provides online hearing screenings and virtual support, allowing customers to receive assistance without needing in-person visits. Eargo's products are available for purchase online or over the phone, and the company emphasizes personalized consultations with licensed hearing professionals through various communication channels. By offering its solutions at approximately half the cost of traditional hearing aids, Eargo aims to enhance the quality of life for people with hearing impairments.

Wheels Up

Series C in 2017
Wheels Up is a membership-based private aviation company that focuses on reducing the upfront cost to fly privately, providing flexibility, service, and safety. Its mobile app enables members to book flights, manage their accounts, and participate in ride-share opportunities. Its members also have given access to the Wheels Down program. The company was founded in 2013 and headquartered in New York, United States.

Tempus

Series C in 2017
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.

Raise

Series C in 2017
Raise is a leading digital prepaid and retail payment platform where consumers save money on every purchase at over 4,000 brands and earn rewards with Raise Pay. As a digital partner to more than 600+ national brands, Raise offers an innovative way for retailers to increase brand loyalty, engagement, and retention by adding value for their core consumers. Since 2013, Raise has saved its millions of members more than $200 million and received $147 million in funding from leading investors including Accel, PayPal, Bessemer Venture Partners, and New Enterprise Associates. Raise is available on both iOS and Android or at raise.com

Amplyx Pharmaceuticals

Series C in 2017
Amplyx Pharmaceuticals is a pre-clinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The company develops innovative therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx Pharmaceuticals was founded in 2006 and is headquartered in San Diego, California.

DataRobot

Series C in 2017
DataRobot, Inc. develops an automated machine learning platform designed to help enterprises build predictive models efficiently. The company's offerings include DataRobot Cloud, a predictive analytics platform available on-site or via the cloud, and DataRobot MLOps, which focuses on the deployment, monitoring, and management of machine learning models within organizations. Additionally, DataRobot Enterprise provides features such as flexible deployment, governance, and support, along with packages aimed at accelerating artificial intelligence projects and education services. The platform is suitable for a diverse range of professionals, including business analysts, data scientists, and IT specialists across various industries like banking, healthcare, and marketing. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot also maintains operations in several international locations, including London, Paris, Kyiv, Tokyo, and Singapore. The company has established strategic partnerships to enhance its offerings in the competitive AI landscape.

Complexa

Series C in 2017
Complexa, Inc. is a biopharmaceutical company based in Berwyn, Pennsylvania, focused on developing therapies for severe and life-threatening diseases associated with fibrosis and inflammation. Founded in 2008, the company is advancing its lead compound, CXA-10, an oral nitrated fatty acid, for the treatment of conditions such as focal segmental glomerulosclerosis and pulmonary arterial hypertension. Complexa utilizes proprietary technology to synthesize endogenous nitro-fatty acids and related mediators, which are designed to address a range of inflammatory, fibrotic, and central nervous system diseases. These nitro-fatty acids function as cell-signaling agents that regulate key inflammatory pathways, thereby enhancing the body's natural mechanisms for resolving tissue injury and promoting repair.

Trevi Therapeutics

Series C in 2017
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an investigational therapy. The company's lead product, Haduvio, is an oral extended-release formulation of nalbuphine currently undergoing Phase IIb/III clinical trials. Trevi Therapeutics is focused on addressing serious neurologically mediated conditions, including chronic pruritus, chronic cough associated with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in Parkinson's disease patients. The ongoing PRISM trial evaluates Haduvio's effectiveness in treating severe pruritus related to prurigo nodularis, highlighting its potential in managing conditions linked by a common pathophysiology involving opioid receptors in the nervous system. Founded in 2011, Trevi Therapeutics aims to provide innovative therapeutic solutions for patients with significant unmet medical needs.

Segment

Series C in 2017
Segment.io, Inc. is a company that specializes in customer data infrastructure, enabling businesses to collect, unify, and connect their customer data across various platforms. Founded in 2011 and headquartered in San Francisco, California, Segment offers a single API that allows organizations to track customer information across multiple devices and channels. This data can be seamlessly sent to a variety of third-party tools, internal systems, or SQL databases. Additionally, Segment provides a product known as Data Lakes, which assists companies in leveraging their customer data to enhance user experiences. The company also maintains an office in Dublin, Ireland, and operates as a subsidiary of Twilio Inc. as of November 2020.

Transfix

Series C in 2017
Transfix, Inc. is a prominent trucking brokerage service provider based in New York, offering digital solutions for freight transportation in the United States. Established in 2010, the company has developed an application that connects shippers with a network of contracted carriers, enabling real-time shipment tracking and performance insights. Transfix serves various industries, including retail, food, beverage, and manufacturing, delivering competitive pricing and reliable service. By leveraging deep industry knowledge and advanced logistics software, Transfix aims to optimize supply chains for its clients. The company has gained recognition for its innovative approach, with notable partnerships that include several top retailers and major food and beverage brands in America.

Nightstar Therapeutics

Series C in 2017
Nightstar Therapeutics plc is a clinical-stage gene therapy company based in London, focused on developing innovative one-time treatments for rare inherited retinal diseases. The company’s lead product candidate, NSR-REP1, is currently in phase 3 clinical development for choroideremia, while NSR-RPGR is undergoing phase 2/3 trials for X-linked retinitis pigmentosa. Additionally, Nightstar is developing NSR-BEST1 and NSR-ABCA4, with the latter in preclinical development for Stargardt disease. Founded in 2017, Nightstar Therapeutics aims to address the unmet medical needs of patients suffering from these conditions.

Topia

Series C in 2017
Topia specializes in Global Talent Mobility, providing a comprehensive platform that allows companies to manage and engage their employees across the globe. Their solution supports various forms of employee movement, including remote work, business travel, and traditional relocations. By automating the entire talent mobility process, Topia enhances employee experiences and helps organizations align mobility strategies with their broader talent and business objectives. The platform addresses critical aspects such as scenario-based planning, compliance risk management, expat payroll, and reporting, facilitating a seamless experience for both employers and employees. Topia serves a diverse range of reputable brands, empowering them to ensure that the right personnel are located where they are needed most, thereby contributing to a competitive advantage in the marketplace.

Movius

Series C in 2017
Movius Interactive Corporation specializes in cloud-based enterprise mobility solutions, primarily offering a Software-as-a-Service (SaaS) platform that extends telecommunication services to mobile devices. This platform includes pre-packaged applications and application programming interfaces, catering to the development needs of businesses. Movius addresses corporate compliance requirements while enhancing productivity, allowing users to manage and analyze their mobile communications effectively through dedicated work phone lines on any device. The company provides support and training services to telecommunication providers, businesses, and end-users both in the United States and internationally. Founded in 1999 and originally known as IP Unity Glenayre, Movius Interactive is headquartered in Duluth, Georgia, with additional locations in Silicon Valley, Bengaluru, Dubai, Madrid, and Johannesburg.

Casper

Series C in 2017
Casper Sleep Inc. is a company that designs and sells a variety of sleep products, including mattresses, pillows, sheets, duvets, and sleep accessories, to consumers in the United States, Canada, and Europe. Originally founded in 2013 as Providence Mattress Company, the business rebranded in 2014 and has since developed its products in-house by leveraging the expertise of product engineers. Casper aims to provide quality sleep solutions by selling directly to consumers through its e-commerce platform, 60 retail stores, and various retail partners, thereby eliminating inflated prices associated with commission-driven sales. In addition to its core offerings, Casper has expanded its product line to include bedroom furniture and sleep technology, catering to a diverse range of customer needs. The company is headquartered in New York, New York.

Earlens

Series C in 2017
Earlens is a privately held medical technology company committed to transforming the hearing experience for millions of people who suffer from hearing loss.The company has developed the Earlens Contact Hearing Solution, which directly activates natural hearing, delivering the broadest bandwidth available today and superior sound quality. This revolutionary, non-surgical hearing solution uses a small lens to vibrate the eardrum, replicating the natural hearing process. The Earlens Contact Hearing Solution received FDA clearance in 2019 for a second generation of the Earlens technology. Unlike traditional hearing aids, which are in effect tiny speakers that simply turn up the volume on air conducted sound, the Earlens Contact Hearing Solution™ is the world’s first to deliver sound directly to the eardrum.

Synlogic

Series C in 2017
Synlogic, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, specializing in the discovery and development of synthetic biotic medicines aimed at treating metabolic, inflammatory, and cancer-related diseases. The company’s lead therapeutic program, SYNB1618, is an oral therapy currently in Phase I/IIa clinical trials for the treatment of phenylketonuria. Additionally, Synlogic is developing SYNB1891, an intratumoral synthetic biotic medicine that is undergoing Phase I clinical trials for the treatment of solid tumors and lymphoma. The company is also exploring synthetic biotics for more common conditions, including inflammatory bowel disease and secondary hyperoxaluria. Synlogic has established a collaboration with Ginkgo Bioworks to advance its development of these innovative therapies.

Robinhood

Series C in 2017
Robinhood Financial LLC is an online discount stock brokerage that provides self-directed investors with a platform to trade a variety of financial instruments, including stocks, options, exchange-traded funds (ETFs), and cryptocurrencies, without incurring commission fees. Established in 2013 by Vladimir Tenev and Baiju Bhatt and headquartered in Menlo Park, California, the firm aims to democratize access to financial markets, making trading more accessible to a broader audience. In addition to trading services, Robinhood also offers cash management accounts, enhancing its financial service offerings. The company operates as a subsidiary of Robinhood Markets, Inc., which was incorporated the same year.

Gladly

Series C in 2017
Gladly is a customer service platform that enables B2C companies to focus on people talking to people throughout a lifetime of naturally productive conversations. With Gladly, customers are at the center and brands can communicate with their customers seamlessly across any channel from voice, email, messaging, chat, and social media. Agents are empowered, customers feel known, and companies build love and loyalty through consistently positive experiences. Gladly is based in San Francisco and funded by Greylock Partners, GGV Capital, NEA, and JetBlue Ventures.

Reltio

Series C in 2017
Innovative Global 2000 companies trust Reltio to manage their mission-critical data to win in the experience economy. Reltio Connected Customer 360 is at the heart of customer experience to drive hyper-personalization, accelerate real-time operations, and simplify compliance with customer consent and privacy laws. It’s an award-winning cloud-native platform that enables business agility, real-time operations at enterprise scale, and insight-ready data for big ideas. Reltio customers include AstraZeneca, HP, Inc., PennyMac, Fairview Health, and MGM Resorts International. Cloud platform providers, AWS and Google Cloud, technology partners, Salesforce/MuleSoft, Talend, and influential strategy partners, Accenture Interactive, Deloitte, IQVIA, Dun & Bradstreet, and many others, partner with Reltio for a trusted customer data foundation.

Branch

Series C in 2017
Branch is a developer of deep linking technology used to gain and retain mobile app users. Its deep linking technology is used to build user-to-user referral programs with features, including rewarded referrals, content sharing, deep-views, download banner, and personal onboarding that enable users to customize the whole app experience that makes discovering apps and app content easier. Branch was founded in 2014 and is headquartered in Redwood City, California.

MasterClass

Series C in 2017
MasterClass, founded in 2015, is an online education platform that offers video courses taught by renowned experts across various fields. The platform provides users with the opportunity to learn directly from celebrated figures such as Anna Wintour, Timbaland, and Neil Gaiman, among others. With a subscription model, users can access hundreds of lessons featuring over 85 prominent personalities, covering diverse topics from cooking to writing and sports. MasterClass aims to democratize high-quality education by making it accessible anytime and anywhere through its All-Access Pass.

Moximed

Series C in 2017
Moximed, Inc. is focused on developing joint-preserving solutions for patients suffering from knee osteoarthritis. The company's primary product, the Atlas System, functions as an implantable joint unloader, similar to a shock absorber, specifically targeting individuals experiencing pain in the medial compartment of the knee. This innovative approach aims to alleviate joint pain, reduce dynamic load, and potentially delay the necessity for more invasive surgical interventions. Moximed seeks to enhance the standard of care for osteoarthritis patients, helping them maintain an active lifestyle while serving both patients and medical professionals globally. Established in 2006 and headquartered in Hayward, California, Moximed was previously known as ExploraMed NC4, Inc.

HackerOne

Series C in 2017
HackerOne, founded in 2012 and headquartered in San Francisco, develops a hacker-powered security platform that connects businesses with penetration testers and cybersecurity researchers. The platform offers various services, including bug bounty solutions and vulnerability disclosure programs, which help organizations identify and mitigate security risks before they can be exploited. By collaborating with a global community of ethical hackers, HackerOne assists companies in enhancing their vulnerability coordination processes, ultimately protecting consumer data and trust. With additional offices in London, New York City, Singapore, and the Netherlands, HackerOne plays a crucial role in facilitating communication between businesses and security experts to address relevant security issues effectively.

Desktop Metal

Series C in 2017
Desktop Metal, Inc. specializes in additive manufacturing solutions tailored for engineers, designers, and manufacturers across various industries, including automotive, aerospace, healthcare, and consumer products. Founded in 2015 and headquartered in Burlington, Massachusetts, the company offers several products, such as the Production System for industrial manufacturing, the Shop System for machine and job shops, the Studio System for office environments, and Fiber, a desktop 3D printer. By focusing on the entire production process from prototyping to mass production, Desktop Metal aims to transform how metal parts are designed and manufactured. The company has secured significant equity funding from notable investors, which has helped build a team of experts in materials science, hardware and software engineering, and design.

ClearMotion

Series C in 2017
ClearMotion, Inc., an automotive technology company, develops a suspension system that makes automotive systems that use a combination of hardware and software to anticipate, absorb, and counteract shocks and vibrations that cars pick up from the road. It specializes in suspension technology, road surface mapping, and active seating motion control aspects. ClearMotion, Inc. was formerly known as Levant Power Corporation and changed its name to ClearMotion, Inc. in January 2017. The company was incorporated in 2008 and is based in Billerica, Massachusetts with an operation in Nuneaton, United Kingdom.

ClearMotion

Series C in 2017
ClearMotion, Inc., an automotive technology company, develops a suspension system that makes automotive systems that use a combination of hardware and software to anticipate, absorb, and counteract shocks and vibrations that cars pick up from the road. It specializes in suspension technology, road surface mapping, and active seating motion control aspects. ClearMotion, Inc. was formerly known as Levant Power Corporation and changed its name to ClearMotion, Inc. in January 2017. The company was incorporated in 2008 and is based in Billerica, Massachusetts with an operation in Nuneaton, United Kingdom.

Letgo

Series C in 2017
Letgo is a popular mobile application that facilitates the buying and selling of second-hand goods locally, boasting over 100 million downloads and 400 million listings. Founded in 2015 by Alec Oxenford and Jordi Castello, later joined by Enrique Linares, Letgo has become a leading marketplace in the United States, offering a diverse range of products, including electronics, vehicles, clothing, and furniture. The app incorporates innovative features such as image recognition and video listings, which streamline the listing process by automatically suggesting titles, prices, and categories based on user-uploaded photos. This user-friendly approach allows individuals to easily declutter their homes and discover great deals nearby.

Bitglass

Series C in 2017
Bitglass, Inc. offers security solutions designed to protect sensitive data for businesses operating in cloud and mobile environments. Founded in 2013 and based in Campbell, California, the company provides tools that automatically segment, track, and secure confidential information while maintaining employee privacy. Its mobile security solutions deliver alerts and insights regarding suspicious activities, along with warnings about potential policy violations and security issues. Bitglass's cloud solutions enable organizations to monitor their sensitive data and receive notifications about data leakage and other security threats. The company combines multiple technologies, including a leading cloud access security broker, an on-device secure web gateway, and zero-trust network access, to facilitate secure interactions across various platforms. Additionally, Bitglass has regional offices in Toronto, Canada.

Databricks

Series C in 2016
Databricks Inc. offers a unified data analytics cloud platform designed to streamline data engineering and collaborative data science. The company provides a cloud-based platform that enables developers and data scientists to integrate data seamlessly, conduct real-time experimentation, and deploy production applications efficiently. Key products include Databricks Delta, which combines the scalability of a data warehouse with the low latency of streaming data ingestion, MLflow for managing the machine learning lifecycle, and Delta Lake, an open-source technology for handling both batch and streaming data. Databricks serves a diverse range of industries, including advertising, finance, healthcare, and manufacturing, among others. Founded in 2013 and headquartered in San Francisco, California, the company also has a presence in London, Amsterdam, and Bengaluru, and maintains strategic partnerships with several organizations to enhance its offerings.

Datrium

Series C in 2016
Datrium is the leader in tier 1 hyperconverged infrastructure (HCI) for hybrid clouds. Datrium converges tier 1 HCI, scale-out backup and cloud disaster recovery for vastly simpler administration, protection of hybrid cloud infrastructure, and higher IO performance than available with traditional HCI alternatives. Founded in 2012, Datrium is headquartered in Sunnyvale, California, United States.